Cell Microsystems Names Industry Veterans as VP of Product Development and VP of Strategic Marketing

/in , /by

Aaron Kennington and Kap Kumar join the Company as VP of Product Development and VP of Strategic Marketing, respectively. DURHAM, NC, UNITED STATES — Cell Microsystems Inc, a developer and manufacturer of innovative products for single cell workflows, announced today that Aaron Kennington and Kap Kumar joined the Company as VP of Product Development and VP of […]

Read more →

Ionpath Receives Strategic Investment to Support Spatial Proteomics Innovation

/in , /by

New funding will be used to advance Ionpath’s MIBI technology in translational research and precision medicine MENLO PARK, Calif. — Ionpath, Inc., a leader in high-definition spatial proteomics, today announced that Thermo Fisher Scientific, the world leader in serving science, has made a strategic investment in the company. Details of the investment are not being […]

Read more →

QIAGEN proposes expansion of Supervisory Board

/in , , , , , , , /by

Dr. Eva Pisa proposed as a new member to the Supervisory Board, contributes significant leadership experience in Life Science and Molecular Diagnostics industry All seven current Supervisory Board members to stand for re-election for one-year terms Annual General Meeting to be held on June 23, 2022, in Venlo, the Netherlands VENLO, the Netherlands —  QIAGEN […]

Read more →

Curiox Biosystems Establishes a Scientific Advisory Board

/in , , , /by

WOBURN, Mass. — Curiox Biosystems, Inc., a global leader in biological sample preparation for life science research, has formed a Scientific Advisory Board (SAB) to accelerate the company’s rapid expansion. The SAB includes experts in microengineering and microfluidics as well as noteworthy scientists in the fields of oncology and diagnostic flow cytometry. It will provide […]

Read more →

bit.bio’s new Huntington’s Disease human cell model, for in vitro research and drug discovery

/in , , , /by

CAMBRIDGE, UK – bit.bio’s new ioGlutamatergic Neurons HTT50CAG/WT provide a human, cell-based, in vitro model of Huntington’s Disease (HD) that accurately reflects the disease genotype. Offering industry-leading consistency and scalability, this first product from the new ioDisease Model portfolio has been developed to support key applications within drug discovery including target identification and high-throughput screening. The life sciences industry is challenged […]

Read more →

Sphere Fluidics strengthens commercial team with three new senior hires

/in , /by

Evelyn Stevenson joins as Director of Product Management, Ravi Girdhar as Director of Sales in the EMEA region, and Denise Emsden as Vice-President of People and Organizational Development Key appointments form part of broader ongoing recruitment plans to support expanded operations and product development Cambridge, UK: Sphere Fluidics, a company developing single cell analysis systems […]

Read more →

Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets

/in , , , /by

Maxwell™ Preclinical MRI Magnets Do Not Require Liquid Helium, Facilitate Siting LONDON —  At the ISMRM 2022 conference, Bruker today announced the launch of innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio. Following the success of its BioSpec® Maxwell 3 Tesla model, the new range of Maxwell 7 Tesla […]

Read more →

LUMICKS Appoints Andre Nel as Chief Financial Officer

/in , /by

Life Sciences Finance Veteran To Help Company Scale Globally Amsterdam, the Netherlands – LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity analysis, today announced that Andre Nel has been appointed Chief Financial Officer. He will be based in the Company’s headquarters in Amsterdam. Olivier Heyning, CEO of LUMICKS, […]

Read more →